Perfil
John K.
Cini was the founder of Sonnet BioTherapeutics Holdings, Inc., founded in 2011, where the title held was Chief Scientific Officer from 2020 to 2025.
Dr. Cini is the founder of Sonnet BioTherapeutics, Inc., founded in 2015, holding the title of Chief Scientific Officer starting in 2015.
Former jobs include Executive Director at Medarex, Inc. and Vice President-Discovery & Development Sciences at Outlook Therapeutics, Inc. from 2011 to 2015.
Education includes a doctorate from the University of North Texas.
Cargos activos de John Cini
| Empresas | Cargo | Inicio |
|---|---|---|
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Fundador | 01/01/2015 |
Antiguos cargos conocidos de John Cini.
| Empresas | Cargo | Fin |
|---|---|---|
| SONNET BIOTHERAPEUTICS | Fundador | 02/12/2025 |
| OUTLOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2015 |
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Director/Miembro de la Junta | - |
Formación de John Cini.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
University of North Texas
University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Sonnet BioTherapeutics Holdings, Inc.
Sonnet BioTherapeutics Holdings, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- John Cini
















